CreditReports.dk
HomeScreen companies

Draupnir Bio ApS Financials, key figures and credit report

CVR number: 38546880 Established 2017 Industry: 72 Scientific research and development
Company contact details
Nordre Fasanvej 215, 2000 Frederiksberg dannemann@draupnir.bio tel: 51500560 www.draupnir.bio
Net sales 45 120.0 kDKK FY 2025
EBIT margin -21.1 % FY 2025
Net debt -34 014.0 kDKK FY 2025 -40.4% vs 2024
Quick ratio 1.8 FY 2025 -2.5 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales45 120.00
Other operating income1 123.004 793.00185.0072.00
Costs of manufacturing-14 295.00
External services-46 693.00-20 826.00-31 713.00-22 713.00-24 858.00
Gross profit-46 693.00-19 703.00-26 920.00-22 528.006 039.00
Employee benefit expenses-23 292.00-22 904.00-17 104.00-21 224.00-13 288.00
Other operating expenses91.001.00
Total depreciation-1 767.00-2 430.00-2 413.00-2 398.00-2 269.00
EBIT-71 752.00-45 037.00-46 346.00-46 149.00-9 518.00
Other financial income45.0091.00238.00656.001 216.00
Other financial expenses- 710.00- 540.00- 319.00- 250.00-5 896.00
Pre-tax profit-72 417.00-45 486.00-46 518.00-45 744.00-14 198.00
Income taxes5 373.005 596.005 352.005 430.001 888.00
Net earnings-67 044.00-39 890.00-41 166.00-40 314.00-12 310.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Other tangible assets4 995.004 144.002 875.001 759.00634.00
Tangible assets total4 995.004 144.002 875.001 759.00634.00
Other non-current investments5 123.003 933.002 796.001 643.00512.00
Investments total5 123.003 933.002 796.001 643.00512.00
Long term receivables total
Inventories total
Prepayments and accrued income691.00818.00340.00619.00291.00
Current other receivables2 244.001 783.002 936.001 290.001 639.00
Current deferred tax assets5 500.005 500.005 500.005 500.001 982.00
Short term receivables total8 435.008 101.008 776.007 409.003 912.00
Cash and bank deposits49 312.0012 205.0021 745.0024 222.0034 014.00
Cash and cash equivalents49 312.0012 205.0021 745.0024 222.0034 014.00
Balance sheet total (assets)67 865.0028 383.0036 192.0035 033.0039 072.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital513.00513.00992.001 280.001 280.00
Retained earnings119 997.0057 943.0069 560.0066 668.0026 286.00
Profit of the financial year-67 044.00-39 890.00-41 166.00-40 314.00-12 310.00
Shareholders equity total53 466.0018 566.0029 386.0027 634.0015 256.00
Non-current leasing loans3 766.002 632.001 416.001 416.00
Non-current other liabilities3 172.00
Non-current liabilities total3 766.002 632.001 416.001 416.003 172.00
Current leasing loans1 055.001 133.001 217.001 305.00112.00
Current trade creditors4 893.003 393.002 501.004 007.004 672.00
Short-term deferred tax liabilities127.0031.0065.0070.0094.00
Other non-interest bearing current liabilities2 912.002 628.001 607.001 905.001 051.00
Current provisions1 646.00
Accruals and deferred income14 715.00
Current liabilities total10 633.007 185.005 390.007 287.0020 644.00
Balance sheet total (liabilities)67 865.0028 383.0036 192.0036 337.0039 072.00
Page generated